ES8200632A1 - Producing gefarnate-containing solid preparations - Google Patents

Producing gefarnate-containing solid preparations

Info

Publication number
ES8200632A1
ES8200632A1 ES478539A ES478539A ES8200632A1 ES 8200632 A1 ES8200632 A1 ES 8200632A1 ES 478539 A ES478539 A ES 478539A ES 478539 A ES478539 A ES 478539A ES 8200632 A1 ES8200632 A1 ES 8200632A1
Authority
ES
Spain
Prior art keywords
gefarnate
containing solid
producing
pka
solid preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478539A
Other languages
Spanish (es)
Other versions
ES478539A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Angeli SpA
Original Assignee
Instituto de Angeli SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA
Publication of ES8200632A1 publication Critical patent/ES8200632A1/en
Publication of ES478539A0 publication Critical patent/ES478539A0/en
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A storage stable Gefarnate-containing solid preparation in which Gefarnate is absorbed on a basic solid carrier such as magnesium silicate, metamagnesium aluminosilicate, magnesium oxide, aluminium hydroxide gel or synthetic hydrotalcite, is obtained by treating the surface of the base with a pKa adjusting agent (other than a mono- or di- saccharide or sugar alcohol) such as citric acid, sodium citrate, polyvinyl alcohol or gum arabic, to bring its surface pKa to 9.3 or less (e.g. 3-8), and then absorbing the Gefarnate onto the treated carrier.
ES478539A 1978-03-14 1979-03-12 A PROCEDURE FOR OBTAINING STABLE SOLID PREPARATIONS CONTAINING GEFARNATE. Granted ES478539A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53029746A JPS6026093B2 (en) 1978-03-14 1978-03-14 Method for producing gefalnate-containing solid preparation

Publications (2)

Publication Number Publication Date
ES8200632A1 true ES8200632A1 (en) 1981-11-01
ES478539A0 ES478539A0 (en) 1981-11-01

Family

ID=12284653

Family Applications (1)

Application Number Title Priority Date Filing Date
ES478539A Granted ES478539A0 (en) 1978-03-14 1979-03-12 A PROCEDURE FOR OBTAINING STABLE SOLID PREPARATIONS CONTAINING GEFARNATE.

Country Status (17)

Country Link
JP (1) JPS6026093B2 (en)
AR (1) AR218711A1 (en)
BE (1) BE874795A (en)
CH (1) CH637827A5 (en)
CS (1) CS207784B2 (en)
ES (1) ES478539A0 (en)
FR (1) FR2419729B1 (en)
GB (1) GB2016271B (en)
HK (1) HK49283A (en)
IE (1) IE48269B1 (en)
IT (1) IT1162282B (en)
MT (1) MTP843B (en)
MX (1) MX5996E (en)
NL (1) NL7901917A (en)
PH (1) PH16903A (en)
PT (1) PT69341A (en)
ZA (1) ZA791103B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (en) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF
ES2055894T3 (en) * 1989-04-07 1994-09-01 Ciba Geigy Ag CONCENTRATES OF PESTICIDED ACTIVE SUBSTANCES AND THEIR PREPARATION.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
JPS5635169B2 (en) * 1974-02-14 1981-08-15
SE421042B (en) * 1976-06-29 1981-11-23 Kockums Chem WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate

Also Published As

Publication number Publication date
CS207784B2 (en) 1981-08-31
FR2419729A1 (en) 1979-10-12
PH16903A (en) 1984-04-10
JPS54122718A (en) 1979-09-22
FR2419729B1 (en) 1988-07-08
NL7901917A (en) 1979-09-18
ES478539A0 (en) 1981-11-01
AR218711A1 (en) 1980-06-30
ZA791103B (en) 1980-03-26
HK49283A (en) 1983-11-11
CH637827A5 (en) 1983-08-31
MX5996E (en) 1984-09-18
GB2016271B (en) 1982-09-02
IT1162282B (en) 1987-03-25
MTP843B (en) 1980-02-11
GB2016271A (en) 1979-09-26
BE874795A (en) 1979-07-02
IE790725L (en) 1979-09-14
JPS6026093B2 (en) 1985-06-21
PT69341A (en) 1979-04-01
IE48269B1 (en) 1984-11-28
IT7948332A0 (en) 1979-03-13

Similar Documents

Publication Publication Date Title
GB1359614A (en) Method for the manufacture of effervescent tablets
NZ216835A (en) Process for the sulphation of glycosaminoglycans, the products of such process and pharmaceutical compositions
IE40361L (en) Bismuth containing pharmaceutical compositions
AU499657B2 (en) Manufacturing process for sodium perborate monohydrate and product obtained according to the process
ES8200632A1 (en) Producing gefarnate-containing solid preparations
JPS52215A (en) Process for preparation of formaldehyde
CA2178195A1 (en) Carbohydrate composition and method for cleaning and disinfecting contact lenses
FR2295753A1 (en) Topical acetylsalicylic acid compsns. - contg. as vehicle an inert, hydrophilic lipophilic penetrant
JPS5218609A (en) Structure of vibration-prof track
IE782515L (en) Treating diarrhoea
JPS549247A (en) Preparation of menthone
JPS5311909A (en) Preparation of detergency
CA966777A (en) Delayed action antiseptic composition and the process for its preparation
JPS52138505A (en) Preparation of granurated metallic soap
JPS5661959A (en) Hard candy of low sweetness
DE3485080D1 (en) LIQUID MAGNESIUM-BASED FORMULATIONS.
JPS5216705A (en) Method of connecting present railway with elevated railway
JPS535071A (en) Regenerating method of ion exchange resin adsorbed fluorosilicic acid ion
JPS5377010A (en) Preparation of hydroxypivalic acid
JPS5323908A (en) Preparation of sodium alkoxide
JPS5422302A (en) Preparation of 1-chloropropene
JPS5473187A (en) Purification of beta-amylase produced by bacillus
NL6817207A (en) Faujasite-type crystalline aluminosilicate
CA856765A (en) Process of producing silicic acid gel with incorporated active charcoal
CA945997A (en) Process for preparation of methylterephthalic acid and 4-methylisophthalic acid

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519